This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tel Aviv University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tal Akriv: Inventor in Genetic Engineering
Introduction
Tal Akriv is an inventor based in Tel Aviv, Israel. His work includes a patent concerning the genetic engineering of B cell receptors and their use in antigen-induced antibody secretion.
Latest Patents
Akriv is associated with 1 patent: “Genetic Engineering of B Cell Receptors and Uses Thereof in Antigen-Induced Antibody Secretion.” The invention focuses on modifying B cell receptors for applications involving antigen-triggered antibody secretion.
Career Highlights
Akriv is associated with Tel Aviv University, where his work connects to research in genetic engineering and antibody-related technologies.
Collaborations
Akriv’s listed coworker is Alessio D. Nahmad, who is also associated with the patent.
Conclusion
Tal Akriv’s patent reflects research into engineered B cell receptors and their potential role in antigen-induced antibody secretion.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile